<DOC>
	<DOC>NCT01550926</DOC>
	<brief_summary>The purpose of this study is to determine whether a new dosage form and dose of orlistat is equivalent to the currently marketed form.</brief_summary>
	<brief_title>A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Orlistat</mesh_term>
	<criteria>age: 1860 years Body Mass Index: 2533 gastrointestinal disease organ transplant HIV, hepatitis B or C food allergies alcohol or other substance abuse smoking</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>orlistat</keyword>
	<keyword>overweight</keyword>
	<keyword>bioequivalence</keyword>
</DOC>